Charles River Laboratories Return on Investment 2010-2024 | CRL

Current and historical return on investment (ROI) values for Charles River Laboratories (CRL) over the last 10 years.
Charles River Laboratories ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2024-09-30 $0.53B $6.11B 8.51%
2024-06-30 $0.56B $6.14B 9.19%
2024-03-31 $0.58B $6.31B 9.47%
2023-12-31 $0.62B $6.25B 10.36%
2023-09-30 $0.65B $5.83B 11.14%
2023-06-30 $0.65B $5.94B 11.24%
2023-03-31 $0.67B $5.86B 11.77%
2022-12-31 $0.65B $5.69B 11.73%
2022-09-30 $0.66B $5.57B 12.16%
2022-06-30 $0.67B $5.65B 12.39%
2022-03-31 $0.62B $5.29B 11.81%
2021-12-31 $0.59B $5.20B 11.84%
2021-09-30 $0.55B $5.33B 11.63%
2021-06-30 $0.52B $5.05B 12.07%
2021-03-31 $0.46B $4.39B 11.38%
2020-12-31 $0.43B $4.05B 10.92%
2020-09-30 $0.41B $3.87B 10.80%
2020-06-30 $0.37B $3.96B 10.05%
2020-03-31 $0.38B $3.98B 10.45%
2019-12-31 $0.35B $3.49B 10.55%
2019-09-30 $0.35B $3.42B 10.77%
2019-06-30 $0.34B $3.50B 10.92%
2019-03-31 $0.33B $2.94B 11.30%
2018-12-31 $0.33B $2.96B 11.91%
2018-09-30 $0.29B $2.91B 11.31%
2018-06-30 $0.28B $2.98B 11.75%
2018-03-31 $0.29B $2.27B 13.20%
2017-12-31 $0.29B $2.16B 13.64%
2017-09-30 $0.30B $2.18B 14.11%
2017-06-30 $0.28B $2.08B 13.52%
2017-03-31 $0.26B $2.05B 12.24%
2016-12-31 $0.24B $2.05B 11.93%
2016-09-30 $0.22B $2.11B 11.76%
2016-06-30 $0.22B $2.17B 12.49%
2016-03-31 $0.21B $1.63B 13.78%
2015-12-31 $0.21B $1.58B 13.71%
2015-09-30 $0.20B $1.54B 13.35%
2015-06-30 $0.19B $1.46B 12.99%
2015-03-31 $0.18B $1.42B 12.65%
2014-12-31 $0.18B $1.42B 12.68%
2014-09-30 $0.16B $1.43B 11.81%
2014-06-30 $0.16B $1.46B 11.76%
2014-03-31 $0.15B $1.31B 11.57%
2013-12-31 $0.15B $1.29B 12.19%
2013-09-30 $0.16B $1.28B 13.41%
2013-06-30 $0.16B $1.27B 13.55%
2013-03-31 $0.17B $1.15B 14.54%
2012-12-31 $0.17B $1.13B 14.38%
2012-09-30 $0.17B $1.14B 14.66%
2012-06-30 $0.17B $1.12B 14.22%
2012-03-31 $0.18B $1.23B 13.96%
2011-12-31 $0.17B $1.23B 13.54%
2011-09-30 $-0.23B $1.26B -17.69%
2011-06-30 $-0.26B $1.32B -18.38%
2011-03-31 $-0.29B $1.33B -18.44%
2010-12-31 $-0.30B $1.36B -17.79%
2010-09-30 $0.10B $1.74B 5.62%
2010-06-30 $0.14B $1.80B 7.65%
2010-03-31 $0.16B $1.82B 8.85%
2009-12-31 $0.17B $1.83B 9.57%
Sector Industry Market Cap Revenue
Medical Medical Services $9.314B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $84.995B 10.55
Cencora (COR) United States $43.734B 16.44
DiDi Global (DIDIY) China $22.941B 0.00
Natera (NTRA) United States $20.871B 0.00
ICON (ICLR) Ireland $16.879B 15.03
Viatris (VTRS) United States $14.478B 4.46
Avantor (AVTR) United States $14.307B 21.45
Revvity (RVTY) United States $13.453B 23.37
BioMerieux (BMXMF) France $12.659B 0.00
CochLear (CHEOY) Australia $11.807B 0.00
Solventum (SOLV) United States $11.540B 0.00
Medpace Holdings (MEDP) United States $10.417B 29.35
Doximity (DOCS) United States $10.302B 60.64
HealthEquity (HQY) United States $8.212B 41.20
Sonic Healthcare (SKHHY) Australia $8.208B 0.00
Bausch + Lomb (BLCO) Canada $6.322B 29.43
Amplifon S.p.A (AMFPF) Italy $5.864B 29.89
Sotera Health (SHC) United States $3.759B 20.11
Organon (OGN) United States $3.719B 3.75
BrightSpring Health Services (BTSG) United States $2.967B 63.11
Surgery Partners (SGRY) United States $2.493B 28.42
Concentras Parent (CON) United States $2.491B 0.00
Ardent Health Partners (ARDT) United States $2.291B 0.00
GeneDx Holdings (WGS) United States $2.069B 0.00
Premier (PINC) United States $2.067B 10.76
PACS (PACS) United States $1.992B 0.00
Alignment Healthcare (ALHC) United States $1.969B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.730B 0.00
GoodRx Holdings (GDRX) United States $1.711B 44.90
Teladoc Health (TDOC) United States $1.544B 0.00
Pediatrix Medical (MD) United States $1.224B 11.98
Progyny (PGNY) United States $1.208B 24.47
Embecta (EMBC) United States $1.161B 8.12
CareDx (CDNA) United States $1.102B 0.00
Establishment Labs Holdings (ESTA) $1.090B 0.00
AMN Healthcare Services Inc (AMN) United States $0.874B 5.91
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.775B 0.00
SBC Medicals (SBC) United States $0.649B 0.00
Auna S.A (AUNA) Luxembourg $0.492B 0.00
InnovAge Holding (INNV) United States $0.478B 0.00
DocGo (DCGO) United States $0.444B 16.73
Sonida Senior Living (SNDA) United States $0.441B 0.00
Enhabit (EHAB) United States $0.387B 33.48
Sera Prognostics (SERA) United States $0.275B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.268B 0.00
LifeMD (LFMD) United States $0.212B 0.00
Biodesix (BDSX) United States $0.198B 0.00
Beauty Health (SKIN) United States $0.176B 0.00
Nutex Health (NUTX) United States $0.160B 0.00
ModivCare (MODV) United States $0.156B 8.44
MultiPlan (MPLN) United States $0.108B 0.00
Ascend Wellness Holdings (AAWH) United States $0.099B 0.00
So-Young (SY) China $0.093B 15.69
IceCure Medical (ICCM) Israel $0.052B 0.00
Singular Genomics Systems (OMIC) United States $0.050B 0.00
OncoCyte (OCX) United States $0.037B 0.00
NeueHealth (NEUE) United States $0.033B 0.87
Pheton Holdings (PTHL) China $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
Co-Diagnostics (CODX) United States $0.023B 0.00
Oncology Institute (TOI) United States $0.016B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
KindlyMD (KDLY) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
Cano Health (CANOQ) United States $0.001B 0.00
Aclarion (ACON) United States $0.001B 0.00